AGT and diabetic kidney disease: To date, administration of ACE2 to mouse models of Ang-II-induced diseases has been shown to reverse the pathological effects of Ang II in diabetic nephropathy [116], heart disease [117], renal oxidative stress [118] as well as reversal of Ang-II-induced hypertension [108].